MRL to Establish Network for Tracking Antimicrobial Resistance

23:29 EDT 11 May 2019 | Drug Discovery Online

MRL Pharmaceutical Services (Herndon, VA), a division of Focus/MRL Inc., has received a seven-year, $3.6 million National Institutes of Health contract to establish a network for tracking the resistance of Staphylococcus aureus (SA)...

Original Article: MRL to Establish Network for Tracking Antimicrobial Resistance

More From BioPortfolio on "MRL to Establish Network for Tracking Antimicrobial Resistance"